Today's top #BusinessModel report is on Life Sciences rebrand.ly/v0njuth Get our free reports on geography of your interest to your mailbox regularly https://rb.gy/cx2upn

1. TRACXN TOP BUSINESS MODELS REPORT
February 09, 2022
LIFE SCIENCES

2. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Contents
Life Sciences Funding - Overview 3
Top Funded Business Models 4
One pagers 9
Appendix 59
2

3. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Funding in last 1 year
3
Oncology $17.6B
Genomics $14.9B
Life Sciences Platforms and Tools $10.5B
Life Sciences Tech $8.9B
Neurology $4.9B
Immunology $4.7B
Y-o-Y Funding
Top Investors by Funding Rounds
Seed
Stage
Y Combinator
SOSV
Entrepreneur First
22
8
6
Early
Stage
RA Capital Management
Alexandria
Orbimed
33
33
32
Late
Stage
RA Capital Management
Fidelity Investments
Orbimed
17
15
15
Funding by Geography
Top Feeds by $ Funding
Top Funding Rounds
United States (65%)
China (10%)
United Kingdom (8%)
France (2%)
Germany (2%)
Switzerland (2%)
Denmark (1%)
Others (10%)
$ Funding # Rounds
Caris Life Sciences
(1996, United States)
$830M - Series D
AboGen
(2012, United States)
$700M - Series A
CMR Surgical
(2014, United Kingdom)
$600M - Series D
LEO Pharma
(1908, Denmark)
$537M - PE
ElevateBio
(2018, United States)
$525M - Series C
Eikon
(2019, United States)
$518M - Series B
Neumora
(2020, United States)
$500M - Series A
Laronde
(2017, United States)
$440M - Series B
Pivot Bio
(2010, United States)
$430M - Series D
XtalPi
(2014, United States)
$400M - Series D
Insitro
(2018, United States)
$400M - Series C
Adagio
(2020, United States)
$336M - Series C

4. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (1/5)
4
Rank Business Model $ Funding # Rounds Top Funding Round Details
1<> 0 Drugs for Multiple Cancer Types $10.6B 269 Sotio | $317M | Series D Link
2<> 0 Life Sciences Research Services $3.4B 106 Immunai | $215M | Series B Link
3▲2 Cheminformatics Software $2.1B 29 XtalPi | $400M | Series D Link
4▼1 Gene Therapy Drugs $1.8B 50 Wugen | $172M | Series B Link
5▲2 Neurological Disorder Drugs $1.8B 40 Neumora | $500M | Series A Link
6▲13 Sequencing-based Genomic Precision Medicine $1.7B 32 Caris Life Sc.. | $830M | Series D Link
7▲4 Autoimmune Disorders Drugs $1.6B 28 Sonoma Biothe.. | $265M | Series B Link
8▲15 Robot Assisted Surgery $1.4B 25 CMR Surgical | $600M | Series D Link
9▲9 Neurodegenerative Disorders Drugs $1.4B 37 Sonoma Biothe.. | $265M | Series B Link
10▲2 Gene Editing Platforms $1.2B 26 Prime Medicine | $200M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

5. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (2/5)
5
Rank Business Model $ Funding # Rounds Top Funding Round Details
11▼5 Cancer Diagnostic Tests $1.1B 13 Freenome | $300M | Series D Link
12▲5 Hematologic Cancer Drugs $1.1B 14 ElevateBio | $525M | Series C Link
13▼5 Genomic Data Analysis Platforms $1.0B 15 Element Biosc.. | $276M | Series C Link
14▼10 Pan-Cancer Drugs $887M 23 Hummingbird B.. | $125M | Series C Link
15<> 0 Genomic Biomarker Discovery Research $878M 7 Freenome | $300M | Series D Link
16▲112 Proteomics Drug Discovery Software $822M 12 Eikon | $518M | Series B Link
17▲8 Diversified $779M 20 CinCor | $143M | Series B Link
18▲146 Biopreservation Devices $775M 4 AboGen | $700M | Series A Link
19▲53 Genomics Sequencing Analysis Software $744M 16 Element Biosc.. | $276M | Series C Link
20▲9 Diabetes Drugs $667M 21 Jaguar Gene T.. | $139M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

6. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (3/5)
6
Rank Business Model $ Funding # Rounds Top Funding Round Details
21▼5 Inflammatory Diseases Drugs $624M 15 Apollo Therap.. | $145M | Series A Link
22▲31 COVID-19 Drugs $588M 11 Adagio | $336M | Series C Link
23▲3 Agrigenomics $575M 21 Inari | $208M | Series D Link
24▲20 Nucleic Acid Sequencing Equipment $574M 12 Nanopore | $271M | Series H Link
25▲10 Synthetic Biology $553M 9 Pivot Bio | $430M | Series D Link
26▲13 Genomics Research Services $543M 30 Caribou Biosc.. | $115M | Series C Link
27▼13 Proteomics Research Services $514M 10 Nautilus Biot.. | $200M | Series C Link
28▲17 Genomic Sequencing Instruments $504M 11 Nanopore | $271M | Series H Link
29▲81 Clinical Trial Patient Recruitment Platforms $442M 9 Reify Health | $220M | Series C Link
30▼17 RNA Interference Platforms $442M 5 Siwei Biotech.. | $188M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

7. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (4/5)
7
Rank Business Model $ Funding # Rounds Top Funding Round Details
31▼22 DNA Liquid Biopsy Diagnostics $442M 14 Jiyinga Techn.. | $116M | Series C Link
32▲41 Ophthalmology Drugs $438M 31 Gyroscope | $148M | Series C Link
33▲55 Decentralized Clinical Trial Management $418M 4 Medable | $304M | Series D Link
34▲3 Genomics Drug Discovery Software $404M 7 Insilico | $255M | Series C Link
35▲138 Cancer Precision Medicine Diagnostic Tests $390M 13 ITM | $109M | Series D Link
36▲30 Metabolic Disorders Drugs $388M 30 Jaguar Gene T.. | $139M | Series B Link
37▼27 Retinal Disorders Drugs $388M 13 Vedere | $77.0M | Series A Link
38▲128 Life Science R&D Workflow Management Software $380M 9 Benchling | $200M | Series E Link
39▲84 Lung Infection Drugs $353M 7 HilleVax | $135M | Series D Link
40▲172 Life Science Molecular Modeling Software $351M 8 Cellarity | $123M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

8. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (5/5)
8
Rank Business Model $ Funding # Rounds Top Funding Round Details
41▲59 Radioisotopes for Imaging $346M 7 SHINE Medical.. | $150M | Series C Link
42▲197 Metabolic Disorders Drugs $346M 9 Jaguar Gene T.. | $139M | Series B Link
43▲241 Intravenous Drug Delivery Systems $326M 7 Enable Inject.. | $215M | Series C Link
44▲35 Nanoparticle Based Drug Delivery Systems $303M 14 Siwei Biotech.. | $188M | Series B Link
45▼9 Ultrasound Imaging Devices $293M 6 Exo | $220M | Series C Link
46▲364 Drug Development Research Assays $292M 42 Cellarity | $123M | Series B Link
47-- Genomics Based Theranostics $291M 10 ITM | $109M | Series D Link
48▼24 At-Home Preventive Genetic Test Kits $290M 11 Variant Bio | $105M | Series B Link
49▲71 Aesthetic Medicines $285M 8 Dermavant | $160M | Series D Link
50▲48 Nucleic Acid Synthesis Instruments $284M 5 DNA Script | $200M | Series C Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

9. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sotio (2010, Czech Republic)
$317M - Series D - Dec 2021
Clover Biopharma (2007, China)
$230M - Series C - Feb 2021
Umoja Biopharma (2019, United States)
$210M - Series B - Jun 2021
Pyxis Oncology (2019, United States)
$173M - Series B - Mar 2021
Vaccitech (2016, United Kingdom)
$168M - Series B - Mar 2021
Century Thera.. (2018, United States)
$160M - Series C - Mar 2021
NMS Group (1965, Italy)
$158M - Series D - Jan 2022
View all 269 Funding Rounds on Tracxn Platform
Drugs for Multiple Cancer Types
01
9
Back to index
Oncology (Guardant Health)
(# Cos: 4539 | $102B)
Drugs (Moderna)
(# Cos: 2918 | $77.6B)
Diversified (Kite Pharma)
(# Cos: 2324 | $61.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$10.6B(▼4.3%)
269(▼2.9%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
194
$61.8B
1656
372
2324
266
Kite Pharma
(2009, United States, $97.7M)
Moderna
(2010, United States, $2.8B)
BeiGene
(2010, United States, $172M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

10. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Immunai (2018, United States)
$215M - Series B - Oct 2021
Arbor Biotech.. (2016, United States)
$215M - Series B - Nov 2021
Wugen (2018, United States)
$172M - Series B - Jul 2021
Mammoth (2017, United States)
$150M - Series D - Sep 2021
Dewpoint Ther.. (2018, United States)
$150M - Series C - Feb 2022
Vividion Ther.. (2016, United States)
$135M - Series C - Feb 2021
Modern Meadow (2011, United States)
$130M - Series C - Apr 2021
View all 106 Funding Rounds on Tracxn Platform
Life Sciences Research Services
02
10
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9801 | $51.8B)
Research Services (Ancestry)
(# Cos: 5015 | $30.8B)
Diversified (Ginkgo Bioworks)
(# Cos: 3373 | $24.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$3.4B(▲20.7%)
106(▼34.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
308
$24.3B
1836
182
3373
160
Ginkgo Bioworks
(2009, United States, $796M)
Human Longevity
(2013, United States, $330M)
Amyris
(2003, United States, $487M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

11. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cheminformatics Software
03
11
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$2.1B(▲50.5%)
29(▲7.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
22
$4.8B
148
7
298
26
Life Sciences Tech (Illumina)
(# Cos: 4838 | $26.4B)
Research & Development (Medidata)
(# Cos: 3903 | $22.1B)
Drug Discovery (Human Longevity)
(# Cos: 1181 | $11.8B)
Cheminformatics (Exscientia)
(# Cos: 298 | $4.8B)
Exscientia
(2012, United Kingdom, $429M)
Schrodinger
(1990, United States, $162M)
ATAI
(2018, Germany, $387M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
XtalPi (2014, United States)
$400M - Series D - Aug 2021
Insitro (2018, United States)
$400M - Series C - Mar 2021
Exscientia (2012, United Kingdom)
$225M - Series D - Apr 2021
InterVenn (2017, United States)
$201M - Series C - Aug 2021
Owkin (2016, France)
$180M - Series B - Nov 2021
ATAI (2018, Germany)
$157M - Series D - Mar 2021
ValoHealth (2019, United States)
$110M - Series B - Mar 2021
View all 29 Funding Rounds on Tracxn Platform

12. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Therapy Drugs
04
12
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.8B(▼32.4%)
50(▼25.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
56
$13.2B
371
83
543
71
Genomics (Ginkgo Bioworks)
(# Cos: 7629 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4145 | $54.3B)
Clinical Genomics (Guardant Health)
(# Cos: 2215 | $40.8B)
Therapeutics (Roche)
(# Cos: 543 | $13.2B)
Roche
(1896, Switzerland)
Alnylam
(2002, United States, $17.0M)
CRISPR Therapeutics
(2013, Switzerland, $127M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Wugen (2018, United States)
$172M - Series B - Jul 2021
Gyroscope (2016, United Kingdom)
$148M - Series C - Mar 2021
Forge Biologics (2020, United States)
$120M - Series B - Apr 2021
Ring Therapeu.. (2018, United States)
$117M - Series B - Jul 2021
Sirnaomics (2007, United States)
$105M - Series E - Jul 2021
Dyno Therapeu.. (2018, United States)
$100M - Series A - May 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
View all 50 Funding Rounds on Tracxn Platform

13. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Neumora (2020, United States)
$500M - Series A - Oct 2021
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
Neurelis (2007, United States)
$115M - Series D - Mar 2021
Septerna (2020, United States)
$100M - Series A - Jan 2022
Vigil (2020, United States)
$90.0M - Series B - Aug 2021
Flare Therape.. (2021, United States)
$82.0M - Series A - May 2021
Beckley Psyt.. (1998, United Kingdom)
$80.0M - Series B - Aug 2021
View all 40 Funding Rounds on Tracxn Platform
Neurological Disorder Drugs
05
13
Back to index
Neurology (MindMaze)
(# Cos: 2589 | $31.0B)
Drugs (Biogen)
(# Cos: 1379 | $24.3B)
Diversified (PureTech Health)
(# Cos: 337 | $6.9B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.8B(▲59.9%)
40(▼16.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
32
$6.9B
241
56
337
40
PureTech Health
(2001, United States, $107M)
Cerevance
(2015, United States, $106M)
Alkermes
(1987, Ireland, $46.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

14. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sequencing-based Genomic Precision
Medicine
06
14
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.7B(▲209%)
32(▲3.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
36
$12.3B
229
50
418
35
Genomics (Ginkgo Bioworks)
(# Cos: 7629 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4145 | $54.3B)
Clinical Genomics (Natera)
(# Cos: 2215 | $40.8B)
Diagnostics (Invitae)
(# Cos: 1635 | $27.0B)
Sequencing-based (Guardant Health)
(# Cos: 1332 | $25.0B)
Precision Medicine (Bluebird Bio)
(# Cos: 418 | $12.3B)
Bluebird Bio
(1992, United States, $136M)
Seattle Genetics
(1998, United States)
UniQure
(1998, Netherlands, $200M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Caris Life Sc.. (1996, United States)
$830M - Series D - May 2021
Deep Genomics (2015, Canada)
$180M - Series C - Jul 2021
SHINE Medical.. (2010, United States)
$150M - Series C - Jun 2021
Omega Therape.. (2016, United States)
$126M - Series C - Mar 2021
BerryOncology (2017, China)
$108M - Series B - Aug 2021
DTx Pharma (2017, United States)
$100M - Series B - Mar 2021
Xilis (2019, United States)
$70.0M - Series A - Jul 2021
View all 32 Funding Rounds on Tracxn Platform

15. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sonoma Biothe.. (2012, United States)
$265M - Series B - Aug 2021
Alumis (2021, United States)
$200M - Series B - Jan 2022
Ventyx Biosci.. (2018, United States)
$114M - Series B - Mar 2021
BioTheryX (2007, United States)
$92.1M - Series E - May 2021
Regor (2018, United States)
$90.0M - Series B - Feb 2021
Kyverna Thera.. (2018, United States)
$85.0M - Series B - Jan 2022
ROME Therapeu.. (2020, United States)
$77.0M - Series B - Sep 2021
View all 28 Funding Rounds on Tracxn Platform
Autoimmune Disorders Drugs
07
15
Back to index
Immunology (Horizon Therapeutics)
(# Cos: 894 | $22.6B)
Drugs (Moderna)
(# Cos: 751 | $21.7B)
Autoimmune Diseases (Biogen)
(# Cos: 122 | $7.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.6B(▲110%)
28(▲40%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$7.2B
81
19
122
20
Biogen
(1978, United States, $80.0M)
Moderna
(2010, United States, $2.8B)
Horizon Therapeutics
(2008, Ireland, $61.8M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

16. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Robot Assisted Surgery
08
16
Back to index
Surgical Instruments (TransEnterix)
(# Cos: 694 | $6.8B)
Robotic Surgery (Intuitive)
(# Cos: 183 | $4.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.4B(▲219%)
25(▲66.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
20
$4.6B
113
13
183
26
Intuitive
(1995, United States, $47.0M)
TransEnterix
(2006, United States, $96.2M)
Corindus Vascular Robo..
(2001, United States, $21.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
CMR Surgical (2014, United Kingdom)
$600M - Series D - Jun 2021
Edge Medical Robotics (2017, China)
$200M - Series C - Nov 2021
Memic Surgery (2013, Israel)
$96.0M - Series D - Apr 2021
Distalmotion (2012, Switzerland)
$90.0M - Series E - Jan 2022
PROCEPT BioRo.. (2009, United States)
$85.0M - Series G - Jun 2021
ColubrisMX (2017, United States)
$76.1M - Series C - Jun 2021
ColubrisMX (2017, United States)
$69.0M - Series B - May 2021
View all 25 Funding Rounds on Tracxn Platform

17. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sonoma Biothe.. (2012, United States)
$265M - Series B - Aug 2021
Amylyx Pharma.. (2013, United States)
$135M - Series C - Jul 2021
Skyhawk Thera.. (2017, United States)
$133M - Series B - Sep 2021
Shape Therape.. (2018, United States)
$112M - Series B - Jul 2021
LEXEO Therape.. (2018, United States)
$100M - Series B - Sep 2021
Verge Genomics (2015, United States)
$98.0M - Series B - Dec 2021
Vanqua Bio (2019, United States)
$85.0M - Series B - Sep 2021
View all 37 Funding Rounds on Tracxn Platform
Neurodegenerative Disorders Drugs
09
17
Back to index
Neurology (MindMaze)
(# Cos: 2589 | $31.0B)
Drugs (AskBio)
(# Cos: 1379 | $24.3B)
Neurodegenerative (Biogen)
(# Cos: 510 | $8.9B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.4B(▲126%)
37(▼2.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
31
$8.9B
354
58
510
51
Biogen
(1978, United States, $80.0M)
AskBio
(2001, United States, $235M)
PTC Therapeutics
(1998, United States, $248M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

18. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Editing Platforms
10
18
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.2B(▲76.3%)
26(▲73.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$2.7B
63
2
92
15
Genomics (MyHeritage)
(# Cos: 7629 | $82.8B)
Enabling Technologies (Illumina)
(# Cos: 1678 | $16.4B)
Technology Platforms (Twist Bioscience)
(# Cos: 358 | $7.9B)
Gene Editing (eGenesis)
(# Cos: 92 | $2.7B)
eGenesis
(2015, United States, $265M)
Locus Biosciences
(2015, United States, $32.3M)
KSQ
(2015, United States, $157M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Prime Medicine (2019, United States)
$200M - Series B - Jul 2021
Graphite Bio (2020, United States)
$151M - Series B - Mar 2021
eGenesis (2015, United States)
$125M - Series C - Mar 2021
Korro Bio (2018, United States)
$116M - Series B - Jan 2022
SalioGen Ther.. (2019, United States)
$115M - Series B - Dec 2021
Scribe Therap.. (2018, United States)
$100M - Series B - Mar 2021
BioHeng (2017, China)
$80.0M - Series B - Mar 2021
View all 26 Funding Rounds on Tracxn Platform

19. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Freenome (2014, United States)
$300M - Series D - Dec 2021
Freenome (2014, United States)
$290M - Series D - Jan 2022
PathAI (2016, United States)
$165M - Series C - May 2021
Jiyinga Technology (2015, China)
$116M - Series C - Jul 2021
Personal Genome (2010, United States)
$103M - Series C - Feb 2021
Color (2013, United States)
$100M - Series E - Nov 2021
Craif (2018, Japan)
$11.3M - Series B - Nov 2021
View all 13 Funding Rounds on Tracxn Platform
Cancer Diagnostic Tests
11
19
Back to index
Oncology (Kite Pharma)
(# Cos: 4539 | $102B)
In-Vitro Diagnostic Tests (Guardant Health)
(# Cos: 1152 | $18.8B)
Pan Cancer (GRAIL)
(# Cos: 194 | $6.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.1B(▼5.6%)
13(▼27.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
24
$6.2B
124
9
194
16
GRAIL
(2016, United States, $2.0B)
PathAI
(2016, United States, $255M)
Color
(2013, United States, $491M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

20. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
ElevateBio (2018, United States)
$525M - Series C - Mar 2021
Wugen (2018, United States)
$172M - Series B - Jul 2021
Monte Rosa Th.. (2020, United States)
$95.0M - Series C - Mar 2021
Heyuan Biotechnology (2018, China)
$64.2M - Series C - Oct 2021
Allterum (2018, United States)
$64.0M - Series A - Jan 2022
Ossium Health (2016, United States)
$63.0M - Series B - Mar 2021
Ajax (2019, United States)
$40.0M - Series C - Jun 2021
View all 14 Funding Rounds on Tracxn Platform
Hematologic Cancer Drugs
12
20
Back to index
Oncology (Guardant Health)
(# Cos: 4539 | $102B)
Drugs (Kite Pharma)
(# Cos: 2918 | $77.6B)
Blood Cancer (Sierra Oncology)
(# Cos: 84 | $4.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.1B(▲76.6%)
14(▲40%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
7
$4.3B
66
21
84
10
Sierra Oncology
(2003, Canada, $75.0M)
Syros Pharmaceuticals
(2012, United States, $124M)
Kiadis Pharma
(1997, Netherlands, $33.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

21. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Element Biosc.. (2017, United States)
$276M - Series C - Jun 2021
Insilico (2014, China)
$255M - Series C - Jun 2021
Benchling (2012, United States)
$200M - Series E - Apr 2021
iCarbonX (2015, China)
$151M - Series D - Apr 2021
Benchling (2012, United States)
$100M - Series F - Nov 2021
54gene (2019, Nigeria)
$25.0M - Series B - Sep 2021
Genoox (2012, Israel)
$8.0M - Series B - Jun 2021
View all 15 Funding Rounds on Tracxn Platform
Genomic Data Analysis Platforms
13
21
Back to index
Genomics (MyHeritage)
(# Cos: 7629 | $82.8B)
Genome Informatics (Schrodinger)
(# Cos: 738 | $5.2B)
Integrative Bioinformatics Platforms
(Human Longevity)
(# Cos: 474 | $4.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.0B(▼3.2%)
15(▼31.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
41
$4.2B
170
6
474
18
Human Longevity
(2013, United States, $330M)
Schrodinger
(1990, United States, $162M)
Quest Diagnostics
(1967, United States)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

22. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Hummingbird Biosc.. (2015, Singapore)
$125M - Series C - May 2021
Anaveon (2017, Switzerland)
$119M - Series B - Dec 2021
Obsidian Ther.. (2015, United States)
$115M - Series B - Sep 2021
Boundless Bio (2018, United States)
$106M - Series B - Apr 2021
Elpiscience (2017, China)
$105M - Series C - May 2021
Wuhan Binhui Biotechn.. (2010, China)
$94.9M - Series C - Feb 2021
Hibercell (2015, United States)
$67.4M - Series B - May 2021
View all 23 Funding Rounds on Tracxn Platform
Pan-Cancer Drugs
14
22
Back to index
Oncology (Guardant Health)
(# Cos: 4539 | $102B)
Drugs (Kite Pharma)
(# Cos: 2918 | $77.6B)
Pan Cancer (GigaGen)
(# Cos: 345 | $7.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$887M(▼51.8%)
23(▼51.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
26
$7.8B
225
45
345
39
GigaGen
(2011, United States, $36.1M)
TScan Therapeutics
(1995, United States, $180M)
Nanobiotix
(2003, France, $11.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

23. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Freenome (2014, United States)
$300M - Series D - Dec 2021
Freenome (2014, United States)
$290M - Series D - Jan 2022
Maze Therapeu.. (2018, United States)
$190M - Series C - Jan 2022
HiFiBiO (2013, France)
$75.0M - Series D - Jun 2021
NeoPhore (2017, United Kingdom)
$21.0M - Series B - Mar 2021
Wobble Genom.. (2020, United Kingdom)
$1.7M - Seed - Sep 2021
NanoBio Designs (2017, United States)
$450K - Seed - Feb 2021
Genomic Biomarker Discovery Research
15
23
Back to index
Genomics (MyHeritage)
(# Cos: 7629 | $82.8B)
Genomics Research (Freenome)
(# Cos: 186 | $4.4B)
Biomarker Discovery (Metabolon)
(# Cos: 93 | $3.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$878M(▲36.7%)
7(▼30%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
7
$3.4B
53
6
93
12
Metabolon
(2000, United States, $148M)
Freenome
(2014, United States, $1.1B)
Lexicon Pharmaceuticals
(1995, United States)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

24. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Proteomics Drug Discovery Software
16
24
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$822M(▲887%)
12(▲50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$1.7B
51
1
119
10
Life Sciences Tech (Illumina)
(# Cos: 4838 | $26.4B)
Research & Development (Medidata)
(# Cos: 3903 | $22.1B)
Drug Discovery (Exscientia)
(# Cos: 1181 | $11.8B)
Proteomics (Cyrus Biotechnology)
(# Cos: 119 | $1.7B)
Cyrus Biotechnology
(2014, United States, $29.3M)
ProteinSimple
(2004, United States, $94.3M)
Vividion Therapeutics
(2016, United States, $271M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Eikon (2019, United States)
$518M - Series B - Jan 2022
Eikon (2019, United States)
$148M - Series A - May 2021
Vividion Ther.. (2016, United States)
$135M - Series C - Feb 2021
Interline The.. (2020, United States)
$92.0M - Series C - May 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
Avilar (2020, United States)
$60.0M - Seed - Nov 2021
Cyrus Biotech.. (2014, United States)
$18.4M - Series B - Dec 2021
View all 12 Funding Rounds on Tracxn Platform

25. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
CinCor (2018, United States)
$143M - Series B - Oct 2021
Tenaya Therap.. (2016, United States)
$106M - Series C - Mar 2021
TransThera Sciences (2016, China)
$100M - Series D - Jul 2021
Cellino (2017, United States)
$80.0M - Series A - Jan 2022
Cardior Pharmaceuti.. (2016, Germany)
$75.2M - Series B - Aug 2021
Juventas Ther.. (2007, United States)
$64.2M - Series C - Oct 2021
TenSixteen (2020, United States)
$40.0M - Series C - Jan 2022
View all 20 Funding Rounds on Tracxn Platform
Diversified
17
25
Back to index
Cardiac and Vascular Disorders (Withings)
(# Cos: 2592 | $30.9B)
Drugs (Moderna)
(# Cos: 344 | $10.5B)
Diversified (Sarepta)
(# Cos: 265 | $6.0B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$779M(▲88.8%)
20(▲17.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
44
$6.0B
207
44
265
18
Sarepta
(1980, United States)
Tenaya Therapeutics
(2016, United States, $248M)
Esperion Therapeutics
(1998, United States, $130M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

26. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
AboGen (2012, United States)
$700M - Series A - Aug 2021
Bridge to Life (2012, United States)
$56.0M - Series A - Aug 2021
Genepoint Biological .. (2015, China)
$18.8M - Series C - Jun 2021
Genepoint Biological .. (2015, China)
Undisclosed - Series C - Jul 2021
Biopreservation Devices
18
26
Back to index
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9801 | $51.8B)
Instruments (Illumina)
(# Cos: 2035 | $11.7B)
Preservation (Stirling Ultracold)
(# Cos: 81 | $911M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$775M(▲1225%)
4(▼50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
6
$911M
39
1
81
4
Stirling Ultracold
(2009, United States, $8.7M)
Brooks Automation
(1978, United States)
Atelerix
(2017, United Kingdom, $1.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

27. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomics Sequencing Analysis Software
19
27
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$744M(▲342%)
16(▼15.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
52
$3.1B
197
9
521
20
Life Sciences Tech (Illumina)
(# Cos: 4838 | $26.4B)
Research & Development (Medidata)
(# Cos: 3903 | $22.1B)
Drug Discovery (Exscientia)
(# Cos: 1181 | $11.8B)
Genomics (Qiagen)
(# Cos: 724 | $4.9B)
Sequencing Analysis (Human Longevity)
(# Cos: 521 | $3.1B)
Human Longevity
(2013, United States, $330M)
Qiagen
(1984, Germany)
Personalis
(2011, United States, $87.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Element Biosc.. (2017, United States)
$276M - Series C - Jun 2021
Deep Genomics (2015, Canada)
$180M - Series C - Jul 2021
Hexagon Bio (2017, United States)
$61.0M - Series B - Sep 2021
Immunitas The.. (2019, United States)
$58.0M - Series B - Aug 2021
CAMP4 (2018, United States)
$45.0M - Series B - Mar 2021
Genomics (2014, United Kingdom)
$30.0M - Series B - Mar 2021
54gene (2019, Nigeria)
$25.0M - Series B - Sep 2021
View all 16 Funding Rounds on Tracxn Platform

28. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Diabetes Drugs
20
28
Back to index
Diabetes (Dexcom)
(# Cos: 901 | $9.4B)
Drugs (Pendulum)
(# Cos: 238 | $5.0B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$667M(▲90.1%)
21(▼16%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$5.0B
166
24
238
26
Pendulum
(2012, United States, $57.0M)
Xeris Pharma
(2005, United States, $155M)
Semma Therapeutics
(2015, United States, $158M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
ViaCyte (1999, United States)
$115M - Series D - Jun 2021
Kriya Therape.. (2012, United States)
$100M - Series B - Jul 2021
Cellino (2017, United States)
$80.0M - Series A - Jan 2022
Gmax Biopharm (2010, China)
$78.0M - Series C - Mar 2021
ViaCyte (1999, United States)
$53.9M - Series D - Apr 2021
Elevian (2017, United States)
$40.0M - Series A - Sep 2021
View all 21 Funding Rounds on Tracxn Platform

29. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Apollo Thera.. (2007, United Kingdom)
$145M - Series A - Jun 2021
Nimbus Therap.. (2009, United States)
$105M - Series D - Jul 2021
Septerna (2020, United States)
$100M - Series A - Jan 2022
Evommune (2020, United States)
$83.0M - Series A - Sep 2021
Aristea Thera.. (2018, United States)
$63.0M - Series B - Jul 2021
Sparrow Pharm.. (2013, United States)
$50.0M - Series A - May 2021
Mestag Thera.. (2020, United Kingdom)
$34.0M - Seed - Aug 2021
View all 15 Funding Rounds on Tracxn Platform
Inflammatory Diseases Drugs
21
29
Back to index
Immunology (Moderna)
(# Cos: 894 | $22.6B)
Drugs (Biogen)
(# Cos: 751 | $21.7B)
Inflammatory Diseases (RedHill
Biopharma)
(# Cos: 234 | $3.9B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$624M(▼2.3%)
15(▼42.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
22
$3.9B
170
23
234
27
RedHill Biopharma
(2009, Israel, $13.5M)
Inotrem
(2013, France, $123M)
Nimbus Therapeutics
(2009, United States, $242M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

30. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
COVID-19 Drugs
22
30
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$588M(▲200%)
11(▲10%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$1.1B
43
8
76
9
Infectious Diseases (Emergent BioSolutions)
(# Cos: 1981 | $27.1B)
Drugs (Roche)
(# Cos: 1071 | $21.9B)
Viral (Moderna)
(# Cos: 482 | $11.8B)
COVID-19 (GigaGen)
(# Cos: 76 | $1.1B)
GigaGen
(2011, United States, $36.1M)
Adagio
(2020, United States, $466M)
NantKwest
(2002, United States, $147M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Adagio (2020, United States)
$336M - Series C - Apr 2021
Nano (2003, United States)
$90.0M - Series C - Mar 2021
Touchlight (2008, United Kingdom)
$58.4M - Series B - Mar 2021
Vaxxinity (2019, United States)
$27.0M - Series B - Mar 2021
Ethris (2009, Germany)
$26.3M - Series B - Feb 2022
ExeVir Bio (2020, Belgium)
$22.7M - Series A - Mar 2021
PharmCADD (2019, South Korea)
$15.5M - Series B - Mar 2021
View all 11 Funding Rounds on Tracxn Platform

31. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Inari (2016, United States)
$208M - Series D - May 2021
Modern Meadow (2011, United States)
$130M - Series C - Apr 2021
Benson Hill (2012, United States)
$125M - Series D - Mar 2021
Equinom (2012, Israel)
$20.0M - Series C - Jun 2021
Biome Makers (2015, United States)
$15.0M - Series B - Aug 2021
Meiogenix (2010, France)
$13.0M - Series A - Dec 2021
Phylos Biosci.. (2014, United States)
$12.2M - Series C - Apr 2021
View all 21 Funding Rounds on Tracxn Platform
Agrigenomics
23
31
Back to index
Genomics (Guardant Health)
(# Cos: 7629 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4145 | $54.3B)
Agrigenomics (Limagrain)
(# Cos: 297 | $4.5B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$575M(▲52.8%)
21( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
35
$4.5B
138
17
297
24
Limagrain
(1965, France, $200M)
Arcadia Biosciences
(2002, United States, $101M)
Pioneer
(1935, United States, $1.7B)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

32. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nucleic Acid Sequencing Equipment
24
32
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$574M(▲154%)
12(▲50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
18
$3.3B
65
7
92
11
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9801 | $51.8B)
Instruments (Zeiss)
(# Cos: 2035 | $11.7B)
Genomics (Nanopore)
(# Cos: 228 | $4.7B)
Nucleic Acid Sequencing (Illumina)
(# Cos: 92 | $3.3B)
Illumina
(1998, United States, $28.0M)
Nanopore
(2005, United Kingdom, $1.3B)
PacBio
(2004, United States, $342M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Nanopore (2005, United Kingdom)
$271M - Series H - May 2021
GenapSys (2010, United States)
$70.0M - Series D - Mar 2021
GeneMind (2012, China)
$63.6M - Series B - Sep 2021
Qi Carbon Technology (2016, China)
$62.5M - Series B - Jun 2021
GeneMind (2012, China)
$38.7M - Series B - Jun 2021
Depixus (2012, France)
$34.5M - Series A - Dec 2021
Jinshi Technology (2017, China)
$15.5M - Series B - Sep 2021
View all 12 Funding Rounds on Tracxn Platform

33. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Pivot Bio (2010, United States)
$430M - Series D - Jul 2021
Antheia (2013, United States)
$73.0M - Series B - Jul 2021
Tavotek (2018, United States)
$35.0M - Series B - Nov 2021
OriCiro Genomics (2018, Japan)
$7.3M - Series B - Jul 2021
Embion Technolo.. (2016, Switzerland)
$4.9M - Series A - Dec 2021
Jiaxing Xinbei Lai Bi.. (2017, China)
$1.5M - Seed - Sep 2021
CC Bio (2018, United Kingdom)
$1.2M - Seed - Aug 2021
View all 9 Funding Rounds on Tracxn Platform
Synthetic Biology
25
33
Back to index
Genomics (Guardant Health)
(# Cos: 7629 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4145 | $54.3B)
Synthetic Biology (Ginkgo Bioworks)
(# Cos: 68 | $3.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$553M(▲80%)
9(▼25%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$3.4B
54
3
68
13
Ginkgo Bioworks
(2009, United States, $796M)
Synlogic Therapeutics
(2013, United States, $34.4M)
Amyris
(2003, United States, $487M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

34. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Caribou Biosc.. (2011, United States)
$115M - Series C - Mar 2021
Verge Genomics (2015, United States)
$98.0M - Series B - Dec 2021
Alchemab (2019, United Kingdom)
$82.7M - Series A - Apr 2021
Bluepha (2014, China)
$66.4M - Series B - Aug 2021
Clear Labs (2014, United States)
$60.0M - Series C - May 2021
Lifebit (2017, United Kingdom)
$60.0M - Series B - Sep 2021
Tavotek (2018, United States)
$35.0M - Series B - Nov 2021
View all 30 Funding Rounds on Tracxn Platform
Genomics Research Services
26
34
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9801 | $51.8B)
Research Services (Ginkgo Bioworks)
(# Cos: 5015 | $30.8B)
Genomics (Ancestry)
(# Cos: 826 | $2.5B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$543M(▲104%)
30(▲3.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
59
$2.5B
243
20
826
28
Ancestry
(1996, United States, $146M)
Personalis
(2011, United States, $87.3M)
Caribou Biosciences
(2011, United States, $157M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

35. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nautilus Biot.. (2016, United States)
$200M - Series C - Jun 2021
Amunix (2006, United States)
$117M - Series B - Mar 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
Amphista The.. (2018, United Kingdom)
$53.0M - Series B - Mar 2021
A-Alpha Bio (2017, United States)
$20.0M - Series A - Sep 2021
Advanced Protei.. (2001, South Korea)
$17.3M - Series B - Nov 2021
Hangzhou Shuyang Biot.. (2015, China)
$12.2M - Series A - Apr 2021
View all 10 Funding Rounds on Tracxn Platform
Proteomics Research Services
27
35
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9801 | $51.8B)
Research Services (Ginkgo Bioworks)
(# Cos: 5015 | $30.8B)
Proteomics (Atomwise)
(# Cos: 275 | $2.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$514M(▼20.6%)
10(▼37.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
21
$2.3B
100
3
275
14
Atomwise
(2012, United States, $175M)
ProteinSimple
(2004, United States, $94.3M)
Biognosys
(2008, Switzerland, $9.1M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

36. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomic Sequencing Instruments
28
36
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$504M(▲127%)
11( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$2.4B
55
5
95
9
Genomics (MyHeritage)
(# Cos: 7629 | $82.8B)
Enabling Technologies (Illumina)
(# Cos: 1678 | $16.4B)
Instrument Systems (10X Genomics)
(# Cos: 317 | $5.0B)
Nucleic Acid Analysis (PacBio)
(# Cos: 190 | $2.8B)
Sequencing (Nanopore)
(# Cos: 95 | $2.4B)
Nanopore
(2005, United Kingdom, $1.3B)
PacBio
(2004, United States, $342M)
QuantuMDx
(2008, United Kingdom, $38.1M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Nanopore (2005, United Kingdom)
$271M - Series H - May 2021
GeneMind (2012, China)
$63.6M - Series B - Sep 2021
Qi Carbon Technology (2016, China)
$62.5M - Series B - Jun 2021
GeneMind (2012, China)
$38.7M - Series B - Jun 2021
Purigen Biosy.. (2012, United States)
$34.4M - Series C - Apr 2021
Jinshi Technology (2017, China)
$15.5M - Series B - Sep 2021
QuantuMDx (2008, United Kingdom)
$15.2M - Series C - Mar 2021
View all 11 Funding Rounds on Tracxn Platform

37. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Clinical Trial Patient Recruitment
Platforms
29
37
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$442M(▲328%)
9(▼18.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
12
$978M
72
-
213
10
Life Sciences Tech (Medable)
(# Cos: 4838 | $26.4B)
Research & Development (Illumina)
(# Cos: 3903 | $22.1B)
Clinical Trials (Medidata)
(# Cos: 955 | $3.7B)
Scientific Sourcing (TrialSpark)
(# Cos: 249 | $1.1B)
Patients (myTomorrows)
(# Cos: 213 | $978M)
myTomorrows
(2012, Netherlands, $22.3M)
TrialSpark
(2014, United States, $250M)
PatientsLikeMe
(2004, United States, $151M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Reify Health (2012, United States)
$220M - Series C - Aug 2021
TrialSpark (2014, United States)
$156M - Series C - Sep 2021
Antidote (2008, United Kingdom)
$23.2M - Series C - Jun 2021
TrialJectory (2017, United States)
$20.0M - Series A - Feb 2022
Mendel Health (2016, United States)
$18.0M - Series A - Jun 2021
BEKHealth (2016, United States)
$4.6M - Series A - Jun 2021
Infiuss (2018, United States)
$500K - Seed - Oct 2021
View all 9 Funding Rounds on Tracxn Platform

38. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
RNA Interference Platforms
30
38
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$442M(▼35.7%)
5( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
5
$1.9B
37
8
56
7
Genomics (MyHeritage)
(# Cos: 7629 | $82.8B)
Enabling Technologies (Illumina)
(# Cos: 1678 | $16.4B)
Technology Platforms (Twist Bioscience)
(# Cos: 358 | $7.9B)
RNA interference (CureVac)
(# Cos: 56 | $1.9B)
CureVac
(2000, Germany, $975M)
Dicerna Pharmaceuticals
(2007, United States, $107M)
Expansion Therapeutics
(2016, United States, $140M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Siwei Biotechnology (2016, China)
$188M - Series B - Jun 2021
Expansion The.. (2016, United States)
$80.0M - Series B - Sep 2021
oRNA (2020, United States)
$80.0M - Series A - Feb 2021
Cardior Pharmaceuti.. (2016, Germany)
$75.2M - Series B - Aug 2021
Envisagenics (2013, United States)
$19.2M - Series A - Sep 2021

39. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
DNA Liquid Biopsy Diagnostics
31
39
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$442M(▼57.4%)
14(▲7.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$4.5B
62
6
97
11
Genomics (Ginkgo Bioworks)
(# Cos: 7629 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4145 | $54.3B)
Clinical Genomics (Roche)
(# Cos: 2215 | $40.8B)
Diagnostics (Natera)
(# Cos: 1635 | $27.0B)
Sequencing-based (Invitae)
(# Cos: 1332 | $25.0B)
Liquid Biopsy (GRAIL)
(# Cos: 252 | $5.7B)
DNA (Guardant Health)
(# Cos: 97 | $4.5B)
Guardant Health
(2012, United States, $558M)
GRAIL
(2016, United States, $2.0B)
Inivata
(2014, United Kingdom, $164M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jiyinga Technology (2015, China)
$116M - Series C - Jul 2021
C2i Genomics (2019, United States)
$100M - Series B - Apr 2021
Scipher Medic.. (2014, United States)
$82.0M - Series C - Mar 2021
Nucleix (2008, Israel)
$55.0M - Series C - Apr 2021
Nucleix (2008, Israel)
$22.0M - Series C - Jan 2022
Gene Solutions (2018, Vietnam)
$15.0M - Series B - Oct 2021
Foresight Dia.. (2020, United States)
$12.5M - Series A - Jun 2021
View all 14 Funding Rounds on Tracxn Platform

40. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Ophthalmology Drugs
32
40
Back to index
Ophthalmology (Zeiss)
(# Cos: 996 | $11.7B)
Drugs (CureVac)
(# Cos: 332 | $6.7B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$438M(▲162%)
31(▼3.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
37
$6.7B
233
46
332
41
CureVac
(2000, Germany, $975M)
Gyroscope
(2016, United Kingdom, $255M)
Ocugen
(2013, United States, $18.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Gyroscope (2016, United Kingdom)
$148M - Series C - Mar 2021
Vedere (2019, United States)
$77.0M - Series A - May 2021
INTERGALACTIC.. (2020, United States)
$75.0M - Series A - Oct 2021
Wuhan Newfoss Biotech.. (2008, China)
$63.0M - Series C - Nov 2021
Oculis (2003, Switzerland)
$57.0M - Series C - May 2021
LENZ Therapeu.. (2021, United States)
$47.0M - Series A - Jun 2021
VivaVision Biotech (2016, China)
$46.0M - Series D - Apr 2021
View all 31 Funding Rounds on Tracxn Platform

41. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Decentralized Clinical Trial Management
33
41
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$418M(▲215%)
4(▲33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
-
$560M
4
-
8
3
Life Sciences Tech (Exscientia)
(# Cos: 4838 | $26.4B)
Research & Development (Illumina)
(# Cos: 3903 | $22.1B)
Clinical Trials (Medidata)
(# Cos: 955 | $3.7B)
Study Implementation (Unlearn)
(# Cos: 492 | $1.9B)
CTMS and EDC (Florence)
(# Cos: 455 | $1.4B)
CTMS (Clinical Ink)
(# Cos: 278 | $1.0B)
Decentralized Clinical Trials
(Medable)
(# Cos: 8 | $560M)
Medable
(2012, United States, $521M)
Curebase
(2017, United States, $19.0M)
Hawthorne Effect
(2015, United States, $20.1M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Medable (2012, United States)
$304M - Series D - Oct 2021
Medable (2012, United States)
$78.0M - Series C - Apr 2021
Hawthorne Eff.. (2015, United States)
$20.0M - Series A - Jun 2021
Curebase (2017, United States)
$16.4M - Series A - May 2021

42. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomics Drug Discovery Software
34
42
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$404M(▲45.4%)
7(▼12.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
3
$1.5B
42
2
103
9
Life Sciences Tech (Illumina)
(# Cos: 4838 | $26.4B)
Research & Development (Medidata)
(# Cos: 3903 | $22.1B)
Drug Discovery (Exscientia)
(# Cos: 1181 | $11.8B)
Genomics (Human Longevity)
(# Cos: 724 | $4.9B)
Drug Development (Insilico)
(# Cos: 103 | $1.5B)
Insilico
(2014, China, $310M)
DNAnexus
(2009, United States, $273M)
Arrakis Therapeutics
(2015, United States, $113M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Insilico (2014, China)
$255M - Series C - Jun 2021
Expansion The.. (2016, United States)
$80.0M - Series B - Sep 2021
Lifebit (2017, United Kingdom)
$60.0M - Series B - Sep 2021
Nostos Genomics (2018, Germany)
$5.6M - Seed - Feb 2022
PhenoTips (2012, Canada)
$2.0M - Seed - Sep 2021
Mass Dynamics (2015, Australia)
$1.5M - Seed - May 2021
LinkDoc (2014, China)
Undisclosed - Series D - Mar 2021

43. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cancer Precision Medicine Diagnostic
Tests
35
43
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$390M(▲651%)
13(▲30%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$768M
37
2
57
9
Oncology (Kite Pharma)
(# Cos: 4539 | $102B)
In-Vitro Diagnostic Tests (Natera)
(# Cos: 1152 | $18.8B)
Diversified (Guardant Health)
(# Cos: 513 | $9.2B)
Precision Medicine (Personalis)
(# Cos: 57 | $768M)
Personalis
(2011, United States, $87.3M)
PierianDx
(2014, United States, $69.3M)
HalioDx
(2015, France, $31.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
ITM (2004, Germany)
$109M - Series D - Apr 2021
Strata Oncology (2015, United States)
$90.0M - Series C - Jul 2021
Xilis (2019, United States)
$70.0M - Series A - Jul 2021
ITM (2004, Germany)
$30.5M - Series D - Jun 2021
PierianDx (2014, United States)
$30.0M - Series C - Nov 2021
Xcell Bioscie.. (2012, United States)
$27.5M - Series B - Jan 2022
GloriousMed (2015, China)
$15.6M - Series B - Oct 2021
View all 13 Funding Rounds on Tracxn Platform

44. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Metabolic Disorders Drugs
36
44
Back to index
Metabolic Diseases (Metabolon)
(# Cos: 421 | $10.9B)
Drugs (MannKind Corp)
(# Cos: 290 | $9.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$388M(▲125%)
30(▼11.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
33
$9.2B
234
62
290
40
MannKind Corp
(1991, United States, $50.0M)
Millendo Therapeutics
(2012, United States, $128M)
Sigilon
(2015, United States, $195M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
ViaCyte (1999, United States)
$115M - Series D - Jun 2021
Shape Therape.. (2018, United States)
$112M - Series B - Jul 2021
Nimbus Therap.. (2009, United States)
$105M - Series D - Jul 2021
Regor (2018, United States)
$90.0M - Series B - Feb 2021
Gmax Biopharm (2010, China)
$78.0M - Series C - Mar 2021
Ceptur Therap.. (2021, United States)
$75.0M - Series A - Jan 2022
View all 30 Funding Rounds on Tracxn Platform

45. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Vedere (2019, United States)
$77.0M - Series A - May 2021
Wuhan Newfoss Biotech.. (2008, China)
$63.0M - Series C - Nov 2021
LENZ Therapeu.. (2021, United States)
$47.0M - Series A - Jun 2021
Sydnexis (2014, United States)
$45.0M - Series B - Aug 2021
Phanes Therap.. (2016, United States)
$40.0M - Series B - May 2021
Visus Therape.. (2019, United States)
$36.0M - Series A - Mar 2021
Coave Therapeutics (2021, France)
$25.1M - Series B - Jul 2021
View all 13 Funding Rounds on Tracxn Platform
Retinal Disorders Drugs
37
45
Back to index
Ophthalmology (Zeiss)
(# Cos: 996 | $11.7B)
Drugs (Gyroscope)
(# Cos: 332 | $6.7B)
Retinal Disorders (CureVac)
(# Cos: 66 | $2.1B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$388M(▼56.6%)
13(▼23.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$2.1B
44
8
66
10
CureVac
(2000, Germany, $975M)
Rezolute
(2012, United States)
Molecular Partners
(2004, Switzerland, $59.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

46. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Life Science R&D Workflow
Management Software
38
46
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$380M(▲575%)
9(▲125%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$556M
18
-
52
4
Life Sciences Tech (Illumina)
(# Cos: 4838 | $26.4B)
Research & Development (Medidata)
(# Cos: 3903 | $22.1B)
Drug Informatics (NantHealth)
(# Cos: 774 | $4.5B)
R&D Workflow Management
(Benchling)
(# Cos: 52 | $556M)
Benchling
(2012, United States, $412M)
Standigm
(2015, South Korea, $68.0M)
Curoverse
(2010, United States, $1.7M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Benchling (2012, United States)
$200M - Series E - Apr 2021
Benchling (2012, United States)
$100M - Series F - Nov 2021
Standigm (2015, South Korea)
$44.5M - Series C - Mar 2021
Code Ocean (2014, United States)
$15.0M - Series A - May 2021
Intelligencia (2018, United States)
$13.8M - Series A - Aug 2021
Standigm (2015, South Korea)
$10.0M - Series C - Jul 2021
Catalytic DS (2010, United States)
$5.8M - Series A - Jun 2021
View all 9 Funding Rounds on Tracxn Platform

47. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
HilleVax (2021, United States)
$135M - Series D - Sep 2021
Icosavax (2017, United States)
$100M - Series B - Apr 2021
Pulmocide (2013, United Kingdom)
$92.0M - Series C - May 2021
Cargene Therapeut.. (2020, Singapore)
$19.2M - Seed - Dec 2021
Pulmotect (2007, United States)
$3.5M - Series A - Mar 2021
Pulmocide (2013, United Kingdom)
$3.5M - Series C - Dec 2021
Peroxitech (2017, United States)
Undisclosed - Seed - May 2021
Lung Infection Drugs
39
47
Back to index
Pulmonology (Mallinckrodt Pharmaceuticals)
(# Cos: 652 | $8.1B)
Drugs (ASLAN Pharmaceuticals)
(# Cos: 192 | $4.9B)
Lung Infections (Icosavax)
(# Cos: 21 | $639M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$353M(▲296%)
7(▲16.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
1
$639M
15
2
21
5
Icosavax
(2017, United States, $152M)
ReViral
(2011, United Kingdom, $121M)
Pulmotect
(2007, United States, $11.4M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

48. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Life Science Molecular Modeling
Software
40
48
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$351M(▲974%)
8(▲14.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$467M
47
-
113
5
Life Sciences Tech (Illumina)
(# Cos: 4838 | $26.4B)
Research & Development (Medidata)
(# Cos: 3903 | $22.1B)
Drug Informatics (Benchling)
(# Cos: 774 | $4.5B)
Molecular Modeling (Asimov)
(# Cos: 113 | $467M)
Asimov
(2017, United States, $4.7M)
Redesign Science
(2015, United States, $17.0M)
Cellarity
(2015, United States, $173M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Cellarity (2015, United States)
$123M - Series B - Feb 2021
Stonewise (2018, China)
$100M - Series B - Apr 2021
Entos (2019, United States)
$53.0M - Series A - Jul 2021
Enveda (2019, United States)
$51.0M - Series A - Jun 2021
Redesign Scie.. (2015, United States)
$15.0M - Seed - Dec 2021
Valence Discovery (2020, Canada)
$7.0M - Seed - Dec 2021
Beijing Chaowei Zhiya.. (2020, China)
$1.5M - Seed - Jul 2021
View all 8 Funding Rounds on Tracxn Platform

49. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
SHINE Medical.. (2010, United States)
$150M - Series C - Jun 2021
ITM (2004, Germany)
$109M - Series D - Apr 2021
APRINOIA (2015, Taiwan)
$40.0M - Series C - Dec 2021
ITM (2004, Germany)
$30.5M - Series D - Jun 2021
ImaginAb (2007, United States)
$12.8M - Series C - Jun 2021
Swiss Nuclides (2017, Switzerland)
$2.8M - Seed - Jun 2021
Coqui Pharma (2009, United States)
$1.3M - Seed - Oct 2021
Radioisotopes for Imaging
41
49
Back to index
Imaging Diagnostics (INSIGHTEC)
(# Cos: 683 | $6.2B)
Accessories (TauRx)
(# Cos: 130 | $1.6B)
Radioisotopes (Advanced Accelerator
Applications)
(# Cos: 80 | $1.5B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$346M(▲194%)
7(▲16.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
12
$1.5B
52
11
80
6
Advanced Accelerator A..
(2002, France, $56.1M)
TauRx
(2002, Singapore, $315M)
Acusphere
(1993, United States, $35.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

50. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
Regor (2018, United States)
$90.0M - Series B - Feb 2021
Atavistik (2021, United States)
$60.0M - Series A - Aug 2021
Rivus Pharmac.. (2019, United States)
$35.0M - Series A - Jun 2021
Stemson Thera.. (2019, United States)
$15.0M - Series A - Jul 2021
RosVivo Thera.. (2021, United States)
$5.5M - Series A - May 2021
Seabelife (2019, France)
$1.2M - Seed - Jun 2021
View all 9 Funding Rounds on Tracxn Platform
Metabolic Disorders Drugs
42
50
Back to index
Metabolic Diseases (Metabolon)
(# Cos: 421 | $10.9B)
Drugs (MannKind Corp)
(# Cos: 290 | $9.2B)
Diversified (VTV Therapeutics)
(# Cos: 33 | $494M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$346M(▲1205%)
9(▲125%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
1
$494M
26
3
33
7
VTV Therapeutics
(1999, United States, $49.0M)
Aria Pharmaceuticals
(2015, United States, $14.3M)
Inversago Pharma
(2015, Canada, $51.8M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

51. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Intravenous Drug Delivery Systems
43
51
Back to index
Drug Delivery (Acorda)
(# Cos: 849 | $7.9B)
Intravenous (Insulet)
(# Cos: 76 | $1.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$326M(▲1865%)
7(▲16.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
9
$1.2B
47
13
76
7
Insulet
(2000, United States, $120M)
Xeris Pharma
(2005, United States, $155M)
Sixfold Bioscience
(2017, United Kingdom, $10.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Enable Inject.. (2010, United States)
$215M - Series C - Jan 2022
Shasqi (2015, United States)
$50.0M - Series B - Nov 2021
Credence MedS.. (2011, United States)
$39.9M - Series D - Sep 2021
PharmaJet (2005, United States)
$15.4M - Series B - Apr 2021
AmacaThera (2015, Canada)
$8.2M - Series A - Feb 2021
AscentX Medical (2008, United States)
$3.0M - Series A - Apr 2021
Sixfold Bios.. (2017, United Kingdom)
$2.2M - Seed - Dec 2021

52. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nanoparticle Based Drug Delivery
Systems
44
52
Back to index
Drug Delivery (Insulet)
(# Cos: 849 | $7.9B)
Nanoparticle Based (Acorda)
(# Cos: 314 | $1.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$303M(▲93.7%)
14(▼12.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
7
$1.4B
173
19
314
12
Acorda
(1995, United States, $66.5M)
Precision Nanosystems
(2010, Canada, $25.4M)
Liquidia
(2004, United States, $90.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Siwei Biotechnology (2016, China)
$188M - Series B - Jun 2021
Genedit (2016, United States)
$26.0M - Series A - Sep 2021
Topas Therapeutics (2016, Germany)
$21.3M - Series B - Jul 2021
Bionaut Labs (2015, United States)
$20.0M - Series B - Mar 2021
RS Research (2015, Turkey)
$12.0M - Series A - Dec 2021
Clene Nanomed.. (2012, United States)
$9.3M - Series D - May 2021
NanoSyrinx (2018, United Kingdom)
$8.5M - Seed - Jul 2021
View all 14 Funding Rounds on Tracxn Platform

53. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Ultrasound Imaging Devices
45
53
Back to index
Imaging Diagnostics (Siemens Healthineers)
(# Cos: 683 | $6.2B)
Ultrasound (INSIGHTEC)
(# Cos: 117 | $1.7B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$293M(▼0.4%)
6( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$1.7B
50
6
117
9
INSIGHTEC
(1999, Israel, $487M)
Butterfly Network
(2011, United States, $350M)
SuperSonic Imagine
(2005, France, $81.6M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Exo (2015, United States)
$220M - Series C - Jul 2021
EchoNous (2015, United States)
$60.0M - Series C - Jun 2021
TechsoMed (2012, Israel)
$7.0M - Series B - Mar 2021
Pulsify Medical (2019, Belgium)
$4.5M - Series A - May 2021
MAUI Imaging (2006, United States)
$1.5M - Series B - Mar 2021
Focus & Fusion (2014, China)
Undisclosed - Series B - May 2021

54. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cellarity (2015, United States)
$123M - Series B - Feb 2021
bit.bio (2016, United Kingdom)
$103M - Series B - Nov 2021
Virtue Diagnostics (2019, China)
$100M - Series B - Jan 2022
Notch Therapeutics (2018, Canada)
$85.0M - Series A - Feb 2021
Alamar Biosci.. (2018, United States)
$80.0M - Series B - Sep 2021
Xilis (2019, United States)
$70.0M - Series A - Jul 2021
Ncardia (2017, Netherlands)
$60.0M - Series C - Nov 2021
View all 42 Funding Rounds on Tracxn Platform
Drug Development Research Assays
46
54
Back to index
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9801 | $51.8B)
Research Assays (Abingdon Health)
(# Cos: 578 | $3.0B)
Drug Discovery (AbCellera)
(# Cos: 377 | $2.7B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$292M(▲6938%)
42(▲82.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
36
$2.7B
197
8
377
38
AbCellera
(2012, Canada, $115M)
Abingdon Health
(2008, United Kingdom, $24.1M)
Ribometrix
(2016, United States, $65.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

55. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomics Based Theranostics
47
55
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$291M( -- )
10( -- )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
3
$618M
21
3
37
4
Genomics (Ginkgo Bioworks)
(# Cos: 7629 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4145 | $54.3B)
Clinical Genomics (Guardant Health)
(# Cos: 2215 | $40.8B)
Theranostics (PierianDx)
(# Cos: 37 | $618M)
PierianDx
(2014, United States, $69.3M)
Ignyta
(2011, United States, $223M)
ITM
(2004, Germany, $139M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
ITM (2004, Germany)
$109M - Series D - Apr 2021
Xiantong Pharmaceutical (2004, China)
$50.0M - Series D - Oct 2021
Xiantong Pharmaceutical (2004, China)
$49.5M - Series D - Feb 2021
ITM (2004, Germany)
$30.5M - Series D - Jun 2021
PierianDx (2014, United States)
$30.0M - Series C - Nov 2021
Treos Bio (2013, United Kingdom)
$14.0M - Series B - Mar 2021
Circular Geno.. (2021, United States)
$4.5M - Seed - Dec 2021
View all 10 Funding Rounds on Tracxn Platform

56. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
At-Home Preventive Genetic Test Kits
48
56
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$290M(▼32.1%)
11(▲83.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$1.5B
54
2
234
8
Genomics (Ginkgo Bioworks)
(# Cos: 7629 | $82.8B)
Applied Genomics (Guardant Health)
(# Cos: 4145 | $54.3B)
Consumer Genomics (MyHeritage)
(# Cos: 848 | $3.7B)
Proactive Healthcare (Everlywell)
(# Cos: 234 | $1.5B)
Everlywell
(2015, United States, $330M)
Color
(2013, United States, $491M)
Viome
(2016, United States, $125M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Variant Bio (2018, United States)
$105M - Series B - Nov 2021
Color (2013, United States)
$100M - Series E - Nov 2021
Viome (2016, United States)
$54.0M - Series B - Nov 2021
Recuro Health (2021, United States)
$15.0M - Series A - Aug 2021
Digbi Health (2018, United States)
$5.4M - Series A - Mar 2021
Orchid (2019, Australia)
$4.5M - Seed - Apr 2021
Viome (2016, United States)
$3.0M - Series B - Feb 2021
View all 11 Funding Rounds on Tracxn Platform

57. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Dermavant (2016, United States)
$160M - Series D - Jun 2021
CytoKi Pharma (2019, Denmark)
$45.0M - Series A - May 2021
Pyramid Bio (2015, United States)
$33.5M - Series C - Oct 2021
Aneira Pharma (2019, United States)
$25.0M - Series B - Apr 2021
Cytovation (2001, Norway)
$20.0M - Series A - Jan 2022
Omeza (2005, United States)
$5.0M - Series A - Mar 2021
Ahammune Biosciences (2016, India)
$1.8M - Seed - Feb 2021
View all 8 Funding Rounds on Tracxn Platform
Aesthetic Medicines
49
57
Back to index
Dermatology (ASLAN Pharmaceuticals)
(# Cos: 875 | $7.3B)
Drugs (Incyte)
(# Cos: 330 | $5.9B)
Aesthetics (Revance Therapeutics)
(# Cos: 243 | $3.9B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$285M(▲213%)
8(▼27.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
44
$3.9B
175
31
243
15
Revance Therapeutics
(2002, United States, $191M)
Sienna Biopharmaceutic..
(2016, United States, $133M)
Castle Creek Pharma
(2015, United States, $663M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

58. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nucleic Acid Synthesis Instruments
50
58
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$284M(▲140%)
5(▲25%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$482M
14
1
28
4
Genomics (MyHeritage)
(# Cos: 7629 | $82.8B)
Enabling Technologies (Illumina)
(# Cos: 1678 | $16.4B)
Instrument Systems (Nanopore)
(# Cos: 317 | $5.0B)
Nucleic Acid Synthesis (Molecular
Assemblies)
(# Cos: 28 | $482M)
Molecular Assemblies
(2013, United States, $52.7M)
DNA Script
(2014, France, $280M)
Nuclera Nucleics
(2013, United Kingdom, $54.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
DNA Script (2014, France)
$200M - Series C - Oct 2021
Nuclera Nucl.. (2013, United Kingdom)
$42.5M - Series B - Feb 2022
Molecular Ass.. (2013, United States)
$24.0M - Series A - Apr 2021
Molecular Ass.. (2013, United States)
$10.0M - Series A - Nov 2021
Switchback Sy.. (2019, United States)
$7.0M - Series A - Oct 2021

59. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Recent funding rounds
Investment Trends
Most Active Investors
Top Funded Business Models
Explore more on Tracxn
All Tech Companies
US Tech Companies
Online Travel Companies
Companies using AI in Healthcare
Companies founded by Stanford GSB Alumni
Soonicorn club in Fintech
Analyst Picks in Israel Tech
Key News in FinTech
Events in Bay Area
Angel Investors in United States
Bluebox
Companies Investment Activity
Miscellaneous
Company Detail Page of DoorDash
Competitors of Freshworks
Cap Table for TransferWise
Financials for Ola
Employee Count for Revolut
Company Due Diligence Exits
Public Companies
Acquired Companies
Most Active Acquirers
Reports
Delhivery - Company Report
Novel Foods - Business Model Report
HRTech - Feed Report
FinTech - Top Business Models Report
US Tech - Top Business Models Report
US Tech - Monthly Report
59

60. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Explore other Reports on Tracxn
HRTech
InsurTech
Food Tech
Novel Foods
Blockchain Network
P2P Remittance
Business Model Reports
FinTech Europe
Consumer Digital SEA
HiTech US
Feed Geo Reports
Company Reports
Monthly Unicorn Report
Unicorn Reports
Transferwise
Coursera
BigBasket
Feed Reports Top Business Models in PA
FinTech
Enterprise Applications
Artificial Intelligence
Geo Monthly Reports
US Tech
Europe Tech
China Tech
Top Business Models in Geo
India Tech
Israel Tech
UK & Ireland Tech
60

61. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Thank You
61
Any and all information either accessed from the website www.tracxn.com or having otherwise originated from Tracxn Technologies Limited including but not limited to the information
contained herein ("Data") is the sole property of Tracxn Technologies Limited (hereinafter "Tracxn"). You shall not recirculate, distribute, transmit, publish, or sell the Data or any portion
thereof in any form or by any means, either for commercial or non-commercial use, or permit any third party to use or distribute the Data or any portion thereof; to any other party, except
with the prior written consent of Tracxn. You may however incorporate insubstantial portions, extracts, abstracts or summaries from the Data into analysis, presentations or tools for your
customers or for your internal use, so long as Tracxn is clearly and visibly identified as the source of information.
For further information please refer to our Terms of Use at www.tracxn.com